leisure time -WSS

leisure time

author：explore 2025-10-01 10:59:51 - browse：44388

Home health and hospice chain Amedisys has chosen a new corporate owner.

Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Alkermes shareholders re
Next article： Venture capitalist Bob Kocher on the state of digital health

focus

WSS

Anxious about a speech? A startup wants you to pop a minty cardiac drug

Doctors on social media are being harassed and cyberbullied

How a billionaire couple greased the skids for Pelosi’s drug pricing bill

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

Readers respond to H5N1 and livestock movements, and more

Too many hospitalized Covid

knowledge

leisure time

hotspot

Novavax promises a turnaround & Lilly roils the obesity market

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

In age of alternative facts, a scholarly course on calling out crap

Resistance to opioid

State Dept. review finds Biden bears some blame for Afghanistan failures

Wearables generate powerful data but its not useful to doctors, yet

Walensky prepares to leave CDC — and Congress — behind

Abbott's new heart device gets FDA advisory panel nod

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Bird flu: Don't repeat Covid's 'health versus the economy' framing

hotspot

With measles on the rise, a personal story of a devastating disease

Why don't Americans have at

Addiction experts warn against a second 'war on drugs'

Readers respond to H5N1 and livestock movements, and more

Congress must protect the remaining independent doctors

Why Eli Lilly’s earnings didn’t quite live up to the hype

entertainment

focus

explore

Wikipedia